ALGORITHM SCIENCES
Algorithm Sciences is focused on optimizing treatment for rare Cardiovascular Diseases. It is a Laidlaw Venture Partners portfolio company.
ALGORITHM SCIENCES
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2013-01-01
Address:
New York, New York, United States
Country:
United States
Status:
Active
Contact:
646-335-5923
Total Funding:
5 M USD
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Kinevant Sciences
Kinevant Sciences is a clinical-stage biopharmaceutical company dedicated to treating rare autoimmune diseases with significant unmet needs.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Laidlaw & Company
Laidlaw & Company investment in Series B - Algorithm Sciences